Johns Hopkins Medicine: Artificial Intelligence Blood Test Provides a Reliable Way to Identify Lung Cancer
June 07, 2024
June 07, 2024
BALTIMORE, Maryland, June 7 (TNSres) -- Johns Hopkins Medicine issued the following news release:
Using artificial intelligence technology to identify patterns of DNA fragments associated with lung cancer, researchers from the Johns Hopkins Kimmel Cancer Center and other institutions have developed and validated a liquid biopsy that may help identify lung cancer earlier.
In a prospective study published June 3 in Cancer Discovery, the team demonstrated that artificial i . . .
Using artificial intelligence technology to identify patterns of DNA fragments associated with lung cancer, researchers from the Johns Hopkins Kimmel Cancer Center and other institutions have developed and validated a liquid biopsy that may help identify lung cancer earlier.
In a prospective study published June 3 in Cancer Discovery, the team demonstrated that artificial i . . .